Lithium and hematology: established and proposed uses

Area of Science:

• Hematology
• Pharmacology
• Oncology

Background:

• Lithium carbonate is a widely used psychiatric medication with known hematological effects, including neutrophilia and increased circulating CD34+ cells.
• Despite extensive hematological research in the 1980s, lithium has not found a definitive clinical application in hematology.
• Existing evidence suggests lithium influences hematopoietic growth factors.

Purpose of the Study:

• To review the evidence for lithium's effects on granulocyte-colony stimulating factor (G-CSF).
• To explore potential therapeutic applications of lithium in managing neutropenia.
• To evaluate the utility of lithium in augmenting hematopoietic stem cell mobilization for bone marrow transplantation.

Main Methods:

• Literature review of studies investigating lithium's impact on hematopoiesis and G-CSF.
• Analysis of existing data on lithium's hematological effects.
• Synthesis of evidence regarding G-CSF augmentation by lithium.

Main Results:

• Lithium administration is associated with increased levels of G-CSF.
• Lithium enhances the effects of G-CSF.
• Evidence suggests lithium can mobilize hematopoietic stem cells.

Conclusions:

• Lithium shows promise as a therapeutic agent for neutropenia due to its ability to increase G-CSF and augment its effects.
• Pre-transplant mobilization of hematopoietic stem cells using lithium may be a beneficial strategy in bone marrow transplantation.
• Further research is warranted to establish definitive clinical uses for lithium in hematology.